What Femovate does

Femovate is a women-owned design capital program, founded in 2022 in Austin, Texas, that supports early-stage femtech, medtech, and digital health startups (pre-seed through Series A) building products for women's health. Operated as a dedicated program under parent company Guidea — a healthcare UX design consultancy — Femovate invests up to $25,000 per selected startup in non-dilutive "design capital" delivered as in-kind product strategy, user research, and design services over a typical 4–8 week engagement. The company has supported between 60 and 75 startups across 16 femtech verticals spanning breast health, maternal health, menopause, pelvic floor health, hormone health, fertility, and other women's health domains.

Femovate's core offerings are delivered through the Femovate Design Capital Program and a set of modular service components: commercialization and GTM strategy, female-centric design research and validation augmented with generative AI, digital prototypes and investor-facing vision demos, and clinical trial / market launch support. Supporting IP includes the proprietary Female-Centric Design Framework, a UX Framework for Digital Health Design covering companion apps, SaMD, and regulated medical devices, and the Femtech Horizon Maps — category-by-category market intelligence products that map gaps and opportunities across women's health verticals. Founder Theresa Neil brings credentials as an O'Reilly author and designer with 25 FDA clearances to her credit and products touching 660M end users through Guidea. The company also maintains a regulatory partnership with Nixon Gwilt Law for FDA submission and compliance guidance.

Femovate's business model is a professional services sponsorship model. Rather than charging fees, the company deploys its own labor capacity as in-kind design capital to selected startups, absorbing the cost on its balance sheet (Guidea is separately Inc. 5000–ranked). The company monetizes indirectly through brand positioning, thought leadership, lead generation for the parent consultancy, and media visibility (Forbes contributor status, SXSW speaker, podcast appearances). Revenue is not separately disclosed; total design capital deployed to date is $2M across the portfolio. Customer acquisition is community-led: applications are accepted on a rolling basis and through startup pitch competitions, and the funnel is reinforced by founder-led content marketing including the forthcoming "Femtech.Design" book (Q1 2026).

Name

Femovate

Legal name

Femovate, LLC

Website

https://femovate.com

Company type

Private

Founded year

2022

Operating status

Operating

Headcount range

1–10 employees

Short description

Femovate is a 2022-founded, women-led design capital program that provides up to $25,000 in non-dilutive in-kind product strategy and UX research services to pre-seed through Series A femtech and women's health startups across 16 verticals.

Ownership category

akta.pro rank

Product category

Femtech Design Consulting Services

NAICS

Other Specialized Design Services (541490)

SIC

Services-Management Consulting Services (8742)

akta.pro primary industry

Corporate Accelerators & Startup Programs (FSANAHAD)

akta.pro secondary industries

Accelerators & Incubators (Investor-Operated) (FSANAAAM), Corporate Learning & Training Content Development (EDAGAKAC)

Keywords

• Femtech design services
• Womens health UX
• Design capital program
• Healthcare product strategy
• Digital health consulting

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales, Technology or R&D, Others

Revenue model

1. Design Capital Sponsorship Program: Femovate invests up to $25k in design capital (in-kind product strategy, research and design services) to each selected startup. This is a non-dilutive sponsorship program for early-stage femtech companies.

Pricing tiers

Go-to-market motion1 record

Distribution channels1 record

Marketing channels6 records

Core offering

Femovate runs a design capital sponsorship program for early-stage femtech startups (pre-seed to Series A), providing up to $25,000 in in-kind product strategy, UX research, and design services per selected startup over 4–8 week bespoke engagements. The offering covers product-market fit validation, GTM strategy, female-centric design, digital prototypes, and clinical trial and market launch support. The program selects startups via rolling applications and pitch competitions, operating as a subsidiary program of the parent design consultancy Guidea.

Product overview

Femovate is a women-owned, women-led design capital program for early-stage femtech startups. The core offering is the Femovate Design Capital Program, which provides up to $25k in design capital through 4-8 week engagements encompassing product market fit strategy, female-centric design services, digital prototypes, and clinical trial/market launch support. Supplementary offerings include the Femtech Horizon Maps series providing market intelligence across 20 women's health verticals, and the upcoming Femtech.Design book by founder Theresa Neil. The company focuses on pre-seed to Series A startups across product types including SaMD, medical devices, digital health, diagnostics, and therapeutics.

Differentiator

Problem solved

Functional benefit

Products and services

• Femovate Design Capital Program A design capital and strategic support program for early-stage femtech startups, providing commercialization strategy, product design, and validation services. Invests up to $25k in design capital per selected startup, typically spanning 4-8 weeks of engagement.
• Product Market Fit and GTM Strategy Services Consulting services for early-stage femtech teams to verify product market fit, commercialization strategy, and product design roadmap for medtech, healthtech, or digital health products. Includes regulatory navigation partnership with Nixon Gwilt Law.
• Female-Centric Design Services Research and design services focused on the unique health and wellness experience women need, using iterative research and design processes augmented with generative AI to accelerate design and validation.
• Digital Prototypes and Vision Demos UX framework services for digital health design with validated interaction and engagement patterns, creating compelling vision demos for investors and development-ready assets for implementation.
• Clinical Trials and Market Launch Support Services preparing products for validation, regulatory and quality review, or pilot/commercial launch, working closely with founding teams and partner teams.
• Femtech Horizon Maps Comprehensive women's health market maps showing category-by-category insights across the continuum of care, revealing gaps and opportunities for innovation. Includes maps for Endometriosis, Menopause/Perimenopause, Maternal Mental Health, Uterine Health, Menstrual Health, Breast Health, Hormone Health, and more planned.
• Femtech.Design Book A product design playbook for women's health innovation authored by Theresa Neil, containing frameworks, strategies, and patterns developed from working with 65+ femtech startups and major healthcare companies. Expected release Q1 2026.

Named customers10 records

Segments2 records

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature3 records

Partnerships

One partnership is on record.

• Nixon Gwilt LawcoreImplementation/ SI/ Consulting PartnerRegulatory experts partnership to help navigate the highly regulated healthcare landscape for FDA submissions and regulatory compliance

Scale indicators10 records

Expansion highlights5 records

Broad incumbents

• frog (Capgemini Invent): Major global design consultancy with health and digital health practice serving medical device, pharma, and consumer health clients. Comparable healthcare product design services at much larger scale and global footprint.
• JLABS (Johnson & Johnson Innovation): Large corporate-backed healthcare accelerator supporting early-stage life sciences and digital health startups. Broader scope (pharma, biotech, consumer) but operates a similar accelerator/program model with portfolio residency.
• IDEO: Major global design consultancy with a healthcare practice serving biopharma, medtech, and digital health clients. Overlapping healthcare product design capabilities but at much larger scale and broader client portfolio.

Direct peers

• Blueprint Health: Digital health accelerator with multi-month mentorship, design and strategy programming for early-stage digital health companies. Comparable accelerator model focused on the same digital health founder segment.
• Redesign Health: Healthcare startup studio that builds, launches, and operates healthcare companies with internal design, strategy, and operational support. Comparable studio-style model of providing design and strategy services to early-stage healthcare ventures.
• Cedars-Sinai Accelerator: Hospital-affiliated healthcare accelerator providing mentorship, design/strategy support, and clinical validation to early-stage health startups. Similar multi-month program model and target segment of healthcare founders.
• Startup Health: Health innovation accelerator with a global portfolio of early-stage health companies receiving structured support, capital, and connections. Comparable portfolio model with multi-year engagement format.
• UCSF Rosenman Institute: Healthtech-focused accelerator supporting early-stage healthcare companies with mentorship, capital connections, and clinical validation. Similar accelerator model and target segment of digital health and medtech founders.
• Springboard Enterprises: Accelerator and scaling program for women-led health and life sciences startups providing commercialization support, mentorship, and access to investors. Comparable in mission, target founder profile (women-led), and program-style engagement with portfolio companies.

Others

• Guidea: Femovate's parent company — a healthcare UX design consultancy recognized on the Inc. 5000. Provides the underlying design capacity Femovate deploys; included to flag the operational relationship rather than market competition.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks5 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/femovate

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Femovate